Oncopeptides Announces First Patient Enrollment In Clinical "Window-Of-Opportunity" Study Evaluating Proprietary Peptide Drug Conjugate Platform In Glioblastoma
Onconetix Inc ONCO
$0.94
▼ -5.13%
($-0.05)
Open
$0.94
Prev Close
$0.99
Day Range
$0.88 – $0.96
52W Range
$0.88 – $270.00
Market Cap
$3.48M
Beta
2.72
EPS (TTM)
$-219.70
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2022-02-18 |
| Shares Out. | 1,150,000 |
| Website | onconetix.com/ ↗ |
| Phone | 13024977115 |
Onconetix Inc is a publicly traded company under the ticker symbol ONCO on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
6 analysts (2024-05-01)